nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I
|
Zeng, Hao |
|
|
11 |
1 |
p. 71-88 |
artikel |
2 |
A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect
|
Zhou, Shuang |
|
|
11 |
1 |
p. 258-270 |
artikel |
3 |
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
|
Bian, Jingwei |
|
|
11 |
1 |
p. 1-12 |
artikel |
4 |
A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated
|
Li, Jinyang |
|
|
11 |
1 |
p. 283-299 |
artikel |
5 |
A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy
|
Zhang, Bingchen |
|
|
11 |
1 |
p. 246-257 |
artikel |
6 |
Botanical drug clinical trial: Common issues and future options
|
Sun, Yu |
|
|
11 |
1 |
p. 300-303 |
artikel |
7 |
Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
|
Chen, Jie |
|
|
11 |
1 |
p. 143-155 |
artikel |
8 |
Cover Story
|
|
|
|
11 |
1 |
p. viii |
artikel |
9 |
Crystal structure of SARS-CoV-2 papain-like protease
|
Gao, Xiaopan |
|
|
11 |
1 |
p. 237-245 |
artikel |
10 |
Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy
|
Chang, Xiaosa |
|
|
11 |
1 |
p. 156-180 |
artikel |
11 |
Discovery of novel diarylamides as orally active diuretics targeting urea transporters
|
Zhang, Shun |
|
|
11 |
1 |
p. 181-202 |
artikel |
12 |
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
|
Zhao, Bing |
|
|
11 |
1 |
p. 203-221 |
artikel |
13 |
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
|
Chen, Xiaofei |
|
|
11 |
1 |
p. 222-236 |
artikel |
14 |
Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
|
Zhou, Zeqi |
|
|
11 |
1 |
p. 304-307 |
artikel |
15 |
Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment
|
Chen, Xiaojie |
|
|
11 |
1 |
p. 271-282 |
artikel |
16 |
Recent advances in drug delivery systems for targeting cancer stem cells
|
Duan, Hongxia |
|
|
11 |
1 |
p. 55-70 |
artikel |
17 |
Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling
|
Ye, Jiezhou |
|
|
11 |
1 |
p. 112-126 |
artikel |
18 |
Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs
|
Yuan, Kai |
|
|
11 |
1 |
p. 30-54 |
artikel |
19 |
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|
Zhou, Yanying |
|
|
11 |
1 |
p. 89-99 |
artikel |
20 |
Table of Contents
|
|
|
|
11 |
1 |
p. iii-viii |
artikel |
21 |
The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis
|
Yan, Zhibin |
|
|
11 |
1 |
p. 100-111 |
artikel |
22 |
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
|
Song, Zhendong |
|
|
11 |
1 |
p. 13-29 |
artikel |
23 |
VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
|
Shen, Yilan |
|
|
11 |
1 |
p. 127-142 |
artikel |